Jade Biosciences (JBIO) Operating Expenses (2020 - 2026)
Jade Biosciences' (JBIO) quarterly Operating Expenses came in at $43.4 million in Q1 2026, up 85.79% YoY from $23.4 million in Q1 2025, and up 24.2% on a QoQ basis from $35.0 million in Q4 2025.
Jade Biosciences (JBIO) Operating Expenses (2020 - 2026) Analysis & Trends
Jade Biosciences (JBIO) has 7 years of Operating Expenses data on file, last reported at $43.4 million in Q1 2026.
- Quarterly Operating Expenses rose 85.79% year-over-year to $43.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $133.6 million (up 33.53% YoY) and the FY2025 annual result came in at $113.5 million, up 52.21% from the prior year.
- Operating Expenses rose to $43.4 million in Q1 2026, from $35.0 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $43.4 million in Q1 2026 to a low of $11.0 million in Q1 2022.
- A 5-year average of $23.1 million and a median of $22.1 million in 2023 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses jumped 296.37% — and 2024, when it decreased 29.97%.
- Tracing JBIO's Operating Expenses over 5 years: stood at $15.9 million in 2022, then surged by 39.2% to $22.1 million in 2023, then jumped by 61.05% to $35.5 million in 2024, then slipped by 1.57% to $35.0 million in 2025, then rose by 24.2% to $43.4 million in 2026.
- The last three Operating Expenses figures came in at $43.4 million (Q1 2026), $35.0 million (Q4 2025), and $27.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Jade Biosciences | 1.57 Bn | 1.11 Bn | - | 58.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 58.92 Mn |
| Mar 31, 2026 | 43.45 Mn |
| Dec 31, 2025 | 34.98 Mn |
| Sep 30, 2025 | 27.40 Mn |
| Jun 30, 2025 | 27.78 Mn |
| Mar 31, 2025 | 23.38 Mn |
| Dec 31, 2024 | 35.54 Mn |
| Sep 30, 2024 | 14.97 Mn |
| Jun 30, 2024 | 26.17 Mn |
| Mar 31, 2024 | 24.62 Mn |
| Dec 31, 2023 | 22.07 Mn |
| Sep 30, 2023 | 21.37 Mn |
| Jun 30, 2023 | 20.34 Mn |
| Mar 31, 2023 | 17.64 Mn |
| Dec 31, 2022 | 15.85 Mn |
| Sep 30, 2022 | 14.15 Mn |
| Jun 30, 2022 | 12.22 Mn |
| Mar 31, 2022 | 11.02 Mn |
| Dec 31, 2021 | 8.27 Mn |
| Sep 30, 2021 | 6.20 Mn |